Translate

Thursday, October 27, 2022

Stem cell-derived organoids mimic human parathyroid tissue

Patient-derived parathyroid organoids (PTOs) could pave the way for future physiology studies and drug-screening applications, as shown in a new study.

from Women's Health News -- ScienceDaily https://ift.tt/gT6Ul2m

Stem cell-derived organoids mimic human parathyroid tissue

Patient-derived parathyroid organoids (PTOs) could pave the way for future physiology studies and drug-screening applications, as shown in a new study.

from Women's Health News -- ScienceDaily https://ift.tt/gT6Ul2m

Wednesday, October 26, 2022

Some breast cancer patients with high responses to chemotherapy may not need surgery

Patients with early-stage breast cancer who had a pathologic complete response (pCR) to neoadjuvant chemotherapy may be able to skip surgery and receive standard radiation treatment with a low chance of disease recurrence, according to a new study.

from Women's Health News -- ScienceDaily https://ift.tt/ipS4xRC

Tuesday, October 25, 2022

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

Researchers have developed a drug that so specifically targets a deadly kind of breast cancer that there are little to no toxic side effects. Next, it will be tested in phase 1 clinical trials in humans.

from Women's Health News -- ScienceDaily https://ift.tt/phSwts9

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

Researchers have developed a drug that so specifically targets a deadly kind of breast cancer that there are little to no toxic side effects. Next, it will be tested in phase 1 clinical trials in humans.

from Women's Health News -- ScienceDaily https://ift.tt/phSwts9

Scientists pinpoint druggable target in aggressive breast cancer

Researchers have set their sights on a new therapeutic target for an aggressive form of breast cancer with limited treatment options. Through a comprehensive and cutting-edge genomic screening method known as CRISPR/CAS9 screening, scientists were able to identify a specific enzyme called UBA1 that revealed itself as an ideal therapeutic target. Using a novel UBA-inhibiting drug called TAK-243, they blocked the cellular function of UBA1 and effectively killed cancer cells in patient-derived breast tumors in mice.

from Women's Health News -- ScienceDaily https://ift.tt/mdChF7e

How intermittent fasting affects female hormones

Intermittent fasting has been shown to be an effective way to lose weight, but critics have worried that the practice may have a negative impact on women's reproductive hormones. Now, a team brings new evidence to the table.

from Women's Health News -- ScienceDaily https://ift.tt/Oz9x3AJ

How intermittent fasting affects female hormones

Intermittent fasting has been shown to be an effective way to lose weight, but critics have worried that the practice may have a negative impact on women's reproductive hormones. Now, a team brings new evidence to the table.

from Women's Health News -- ScienceDaily https://ift.tt/a3ItfE6

Friday, October 21, 2022

Earlier mammograms for women with family history of breast cancer may not be needed

A new study may prompt medical experts to rethink when to start mammograms for women who have a mother, sister or daughter diagnosed with breast cancer.

from Breast Cancer News -- ScienceDaily https://ift.tt/D7nc31q

Earlier mammograms for women with family history of breast cancer may not be needed

A new study may prompt medical experts to rethink when to start mammograms for women who have a mother, sister or daughter diagnosed with breast cancer.

from Women's Health News -- ScienceDaily https://ift.tt/D7nc31q

Earlier mammograms for women with family history of breast cancer may not be needed

A new study may prompt medical experts to rethink when to start mammograms for women who have a mother, sister or daughter diagnosed with breast cancer.

from Women's Health News -- ScienceDaily https://ift.tt/D7nc31q

Wednesday, October 19, 2022

Study sheds light on understudied breast cancer type

A multi-center analysis of patients with invasive lobular carcinoma, or ILC -- the second most common histological subtype of invasive breast cancer in the U.S. -- showed that, despite its prevalence, ILC is detected later and has worse outcomes than the predominant subtype of invasive breast cancer, known as invasive ductal carcinoma (IDC), or no special type.

from Women's Health News -- ScienceDaily https://ift.tt/oLYsp0y

Study sheds light on understudied breast cancer type

A multi-center analysis of patients with invasive lobular carcinoma, or ILC -- the second most common histological subtype of invasive breast cancer in the U.S. -- showed that, despite its prevalence, ILC is detected later and has worse outcomes than the predominant subtype of invasive breast cancer, known as invasive ductal carcinoma (IDC), or no special type.

from Women's Health News -- ScienceDaily https://ift.tt/oLYsp0y

Tuesday, October 18, 2022

Hair straightening chemicals associated with higher uterine cancer risk

Women who used chemical hair straightening products were at higher risk for uterine cancer compared to women who did not report using these products, according to a new study. The researchers found no associations with uterine cancer for other hair products that the women reported using, including hair dyes, bleach, highlights, or perms.

from Women's Health News -- ScienceDaily https://ift.tt/1y0sP72

Hair straightening chemicals associated with higher uterine cancer risk

Women who used chemical hair straightening products were at higher risk for uterine cancer compared to women who did not report using these products, according to a new study. The researchers found no associations with uterine cancer for other hair products that the women reported using, including hair dyes, bleach, highlights, or perms.

from Women's Health News -- ScienceDaily https://ift.tt/1y0sP72

Researchers 3D bioprint breast cancer tumors, treat them in groundbreaking study

Researchers have successfully 3D bioprinted breast cancer tumors and treated them in a breakthrough study to better understand the disease that is one of the leading causes of mortality worldwide.

from Breast Cancer News -- ScienceDaily https://ift.tt/yxBbvcu

Tuesday, October 11, 2022

Experimental treatment approach counters allergic asthma without weakening flu defenses

A new study found that blocking the action of calcium signals in immune cells counters the most common form of asthma without compromising the body's defenses against flu viruses.

from Women's Health News -- ScienceDaily https://ift.tt/FZfBNr8

Monday, October 3, 2022

Long-term study supports link between inflammation and cognitive problems in older breast cancer survivors

Higher levels of a key inflammatory marker were related to older breast cancer survivors reporting cognitive problems, researchers found in one of the first long-term efforts to examine the potential link between chronic inflammation and cognition in older breast cancer survivors.

from Women's Health News -- ScienceDaily https://ift.tt/saBd4NF

Long-term study supports link between inflammation and cognitive problems in older breast cancer survivors

Higher levels of a key inflammatory marker were related to older breast cancer survivors reporting cognitive problems, researchers found in one of the first long-term efforts to examine the potential link between chronic inflammation and cognition in older breast cancer survivors.

from Women's Health News -- ScienceDaily https://ift.tt/saBd4NF